Categories Article Clinical trials Phase II Studies Toxicity Year 2020 Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial Post author By ISNCT Post date May 20, 2022 Radiotherapy and Oncology, 2020 Tags Azami Y., Endo H., Hatazawa J., Hiratsuka J., Hirose K., Iketani S., Imai S., Kato T., Kikuchi Y., Konno A., Murakami M., Nakamura T., Ono K., Ono T., Otsuki N., Radiotherapy and Oncology, Sato M., Seto I., Suzuki M., Takai Y., Takayama K., Tanaka H., Ueki Y., Wada H., Yamaguchi H., Yoshimoto S.